209 related articles for article (PubMed ID: 24925606)
21. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms.
Pantelis C; Stuart GW; Nelson HE; Robbins TW; Barnes TR
Am J Psychiatry; 2001 Aug; 158(8):1276-85. PubMed ID: 11481163
[TBL] [Abstract][Full Text] [Related]
22. [Working memory in schizophrenia: a review].
Kebir O; Tabbane K
Encephale; 2008 Jun; 34(3):289-98. PubMed ID: 18558152
[TBL] [Abstract][Full Text] [Related]
23. Metacognitive awareness of cognitive problems in schizophrenia: exploring the role of symptoms and self-esteem.
Cella M; Swan S; Medin E; Reeder C; Wykes T
Psychol Med; 2014 Feb; 44(3):469-76. PubMed ID: 23734941
[TBL] [Abstract][Full Text] [Related]
24. Extrapyramidal symptoms and neuropsychological deficits in schizophrenia.
Palmer BW; Heaton RK; Jeste DV
Biol Psychiatry; 1999 Mar; 45(6):791-4. PubMed ID: 10188011
[TBL] [Abstract][Full Text] [Related]
25. Clinical and neurocognitive course in early-onset psychosis: a longitudinal study of adolescents with schizophrenia-spectrum disorders.
Wozniak JR; Block EE; White T; Jensen JB; Schulz SC
Early Interv Psychiatry; 2008 Aug; 2(3):169-77. PubMed ID: 21352150
[TBL] [Abstract][Full Text] [Related]
26. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
27. Relationship between changes in metabolic syndrome constituent components over 12 months of treatment and cognitive performance in first-episode schizophrenia.
Luckhoff HK; Kilian S; Olivier MR; Phahladira L; Scheffler F; du Plessis S; Chiliza B; Asmal L; Emsley R
Metab Brain Dis; 2019 Apr; 34(2):469-476. PubMed ID: 30604027
[TBL] [Abstract][Full Text] [Related]
28. Serum testosterone levels are related to cognitive function in men with schizophrenia.
Moore L; Kyaw M; Vercammen A; Lenroot R; Kulkarni J; Curtis J; O'Donnell M; Carr VJ; Shannon Weickert C; Weickert TW
Psychoneuroendocrinology; 2013 Sep; 38(9):1717-28. PubMed ID: 23490072
[TBL] [Abstract][Full Text] [Related]
29. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy.
Lipkovich IA; Deberdt W; Csernansky JG; Sabbe B; Keefe RS; Kollack-Walker S
BMC Psychiatry; 2009 Jul; 9():44. PubMed ID: 19602273
[TBL] [Abstract][Full Text] [Related]
30. Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers.
Barch DM; Carter CS
Schizophr Res; 2005 Sep; 77(1):43-58. PubMed ID: 16005384
[TBL] [Abstract][Full Text] [Related]
31. Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis.
Segarra R; Zabala A; Eguíluz JI; Ojeda N; Elizagarate E; Sánchez P; Ballesteros J; Gutiérrez M
Eur Arch Psychiatry Clin Neurosci; 2011 Jun; 261(4):241-50. PubMed ID: 20839003
[TBL] [Abstract][Full Text] [Related]
32. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P
Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217
[TBL] [Abstract][Full Text] [Related]
33. Everyday memory and laboratory memory tests: general function predictors in schizophrenia and remitted depression.
Fennig S; Mottes A; Ricter-Levin G; Treves I; Levkovitz Y
J Nerv Ment Dis; 2002 Oct; 190(10):677-82. PubMed ID: 12409861
[TBL] [Abstract][Full Text] [Related]
34. Cognitive functioning related to quality of life in schizophrenia.
Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266
[TBL] [Abstract][Full Text] [Related]
35. The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.
Lindenmayer JP; Fregenti S; Kang G; Ozog V; Ljuri I; Khan A; Goldring A; McGurk SR
Schizophr Res; 2017 Jul; 185():154-160. PubMed ID: 28094171
[TBL] [Abstract][Full Text] [Related]
36. HT1001, a proprietary North American ginseng extract, improves working memory in schizophrenia: a double-blind, placebo-controlled study.
Chen EY; Hui CL
Phytother Res; 2012 Aug; 26(8):1166-72. PubMed ID: 22213250
[TBL] [Abstract][Full Text] [Related]
37. Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study.
Impey D; Baddeley A; Nelson R; Labelle A; Knott V
J Neural Transm (Vienna); 2017 Nov; 124(11):1489-1501. PubMed ID: 28864916
[TBL] [Abstract][Full Text] [Related]
38. Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia.
Takahashi S; Ukai S; Kose A; Hashimoto T; Iwatani J; Okumura M; Tsuji T; Shinosaki K
Schizophr Res; 2013 May; 146(1-3):238-43. PubMed ID: 23523695
[TBL] [Abstract][Full Text] [Related]
39. Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia.
Fervaha G; Agid O; Takeuchi H; Lee J; Foussias G; Zakzanis KK; Graff-Guerrero A; Remington G
Schizophr Res; 2015 Feb; 161(2-3):351-6. PubMed ID: 25471015
[TBL] [Abstract][Full Text] [Related]
40. Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study.
Zhou Y; Li G; Li D; Cui H; Ning Y
J Psychopharmacol; 2018 May; 32(5):524-532. PubMed ID: 29493377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
